Structural basis for the regulation of maternal embryonic leucine zipper kinase.

MELK (maternal embryonic leucine zipper kinase), which is a member of the AMPK (AMP-activated protein kinase)-related kinase family, plays important roles in diverse cellular processes and has become a promising drug target for certain cancers. However, the regulatory mechanism of MELK remains elusi...

Full description

Bibliographic Details
Main Authors: Lu-Sha Cao, Jue Wang, Yuling Chen, Haiteng Deng, Zhi-Xin Wang, Jia-Wei Wu
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2013-01-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC3724675?pdf=render
id doaj-563ec604f9ac40a08dbf6f253991ed3b
record_format Article
spelling doaj-563ec604f9ac40a08dbf6f253991ed3b2020-11-25T01:48:04ZengPublic Library of Science (PLoS)PLoS ONE1932-62032013-01-0187e7003110.1371/journal.pone.0070031Structural basis for the regulation of maternal embryonic leucine zipper kinase.Lu-Sha CaoJue WangYuling ChenHaiteng DengZhi-Xin WangJia-Wei WuMELK (maternal embryonic leucine zipper kinase), which is a member of the AMPK (AMP-activated protein kinase)-related kinase family, plays important roles in diverse cellular processes and has become a promising drug target for certain cancers. However, the regulatory mechanism of MELK remains elusive. Here, we report the crystal structure of a fragment of human MELK that contains the kinase domain and ubiquitin-associated (UBA) domain. The UBA domain tightly binds to the back of the kinase domain, which may contribute to the proper conformation and activity of the kinase domain. Interestingly, the activation segment in the kinase domain displays a unique conformation that contains an intramolecular disulfide bond. The structural and biochemical analyses unravel the molecular mechanisms for the autophosphorylation/activation of MELK and the dependence of its catalytic activity on reducing agents. Thus, our results may provide the basis for designing specific MELK inhibitors for cancer treatment.http://europepmc.org/articles/PMC3724675?pdf=render
collection DOAJ
language English
format Article
sources DOAJ
author Lu-Sha Cao
Jue Wang
Yuling Chen
Haiteng Deng
Zhi-Xin Wang
Jia-Wei Wu
spellingShingle Lu-Sha Cao
Jue Wang
Yuling Chen
Haiteng Deng
Zhi-Xin Wang
Jia-Wei Wu
Structural basis for the regulation of maternal embryonic leucine zipper kinase.
PLoS ONE
author_facet Lu-Sha Cao
Jue Wang
Yuling Chen
Haiteng Deng
Zhi-Xin Wang
Jia-Wei Wu
author_sort Lu-Sha Cao
title Structural basis for the regulation of maternal embryonic leucine zipper kinase.
title_short Structural basis for the regulation of maternal embryonic leucine zipper kinase.
title_full Structural basis for the regulation of maternal embryonic leucine zipper kinase.
title_fullStr Structural basis for the regulation of maternal embryonic leucine zipper kinase.
title_full_unstemmed Structural basis for the regulation of maternal embryonic leucine zipper kinase.
title_sort structural basis for the regulation of maternal embryonic leucine zipper kinase.
publisher Public Library of Science (PLoS)
series PLoS ONE
issn 1932-6203
publishDate 2013-01-01
description MELK (maternal embryonic leucine zipper kinase), which is a member of the AMPK (AMP-activated protein kinase)-related kinase family, plays important roles in diverse cellular processes and has become a promising drug target for certain cancers. However, the regulatory mechanism of MELK remains elusive. Here, we report the crystal structure of a fragment of human MELK that contains the kinase domain and ubiquitin-associated (UBA) domain. The UBA domain tightly binds to the back of the kinase domain, which may contribute to the proper conformation and activity of the kinase domain. Interestingly, the activation segment in the kinase domain displays a unique conformation that contains an intramolecular disulfide bond. The structural and biochemical analyses unravel the molecular mechanisms for the autophosphorylation/activation of MELK and the dependence of its catalytic activity on reducing agents. Thus, our results may provide the basis for designing specific MELK inhibitors for cancer treatment.
url http://europepmc.org/articles/PMC3724675?pdf=render
work_keys_str_mv AT lushacao structuralbasisfortheregulationofmaternalembryonicleucinezipperkinase
AT juewang structuralbasisfortheregulationofmaternalembryonicleucinezipperkinase
AT yulingchen structuralbasisfortheregulationofmaternalembryonicleucinezipperkinase
AT haitengdeng structuralbasisfortheregulationofmaternalembryonicleucinezipperkinase
AT zhixinwang structuralbasisfortheregulationofmaternalembryonicleucinezipperkinase
AT jiaweiwu structuralbasisfortheregulationofmaternalembryonicleucinezipperkinase
_version_ 1725013218967945216